Sana Biotechnology For Profit
.jpg)
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.
Investors
Technology:
Other
Industry:
Regenerative medicine
Headquarters:
United States
Investors Number:
2
Total Funding:
$2M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership